MARIA YOLANDA
DIEBOLD LUQUE
PROFESORES TITULARES DE UNIVERSIDAD
Universidade de Santiago de Compostela
Santiago de Compostela, EspañaPublikationen in Zusammenarbeit mit Forschern von Universidade de Santiago de Compostela (11)
2018
-
Improved in vitro corneal delivery of a thrombospondin-1-derived peptide using a liposomal formulation
Experimental Eye Research, Vol. 167, pp. 118-121
-
Sorbitan ester nanoparticles (SENS) as a novel topical ocular drug delivery system: Design, optimization, and in vitro/ex vivo evaluation
International Journal of Pharmaceutics, Vol. 546, Núm. 1-2, pp. 20-30
2017
-
Designing lipid nanoparticles for topical ocular drug delivery
International Journal of Pharmaceutics, Vol. 532, Núm. 1, pp. 204-217
2014
-
Nanoparticles based on naturally-occurring biopolymers as versatile delivery platforms for delicate bioactive molecules: An application for ocular gene silencing
International Journal of Pharmaceutics, Vol. 477, Núm. 1, pp. 12-20
2013
-
A nanomedicine to treat ocular surface inflammation: Performance on an experimental dry eye murine model
Gene Therapy, Vol. 20, Núm. 5, pp. 467-477
2011
-
Expression of MUC5AC in ocular surface epithelial cells using cationized gelatin nanoparticles
Molecular Pharmaceutics, Vol. 8, Núm. 5, pp. 1783-1788
-
Intracellular trafficking of hyaluronic acid-chitosan oligomerbased nanoparticles in cultured human ocular surface cells
Molecular Vision, Vol. 17, pp. 279-290
2010
-
Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles
Cornea, Vol. 29, Núm. 5, pp. 550-558
2007
-
Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP)
Biomaterials, Vol. 28, Núm. 8, pp. 1553-1564
2006
-
Chitosan nanoparticles as a potential drug delivery system for the ocular surface: Toxicity, uptake mechanism and in vivo tolerance
Investigative Ophthalmology and Visual Science, Vol. 47, Núm. 4, pp. 1416-1425
2004
-
Chitosan nanoparticles as new ocular drug delivery systems: In vitro stability, in vivo fate, and cellular toxicity
Pharmaceutical Research, Vol. 21, Núm. 5, pp. 803-810